PTCT PTC Therapeutics, Inc.
PTC Therapeutics, Inc. (PTCT) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
How much of that selling was preplanned? 89% planned / 11% discretionary
Largest single sale: $2.7M.
Where they traded
No open-market insider purchase on record.
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| SCHMERTZLER MICHAEL 2 fills | Director | Sell 10b5-1 | 12,500 | $71.58 | $894.8K | 1,337,204 −0.9% of holding | |
| SCHMERTZLER MICHAEL 2 fills | Director | Sell 10b5-1 | 12,500 | $72.94 | $911.7K | 1,354,720 −0.9% of holding | |
| SCHMERTZLER MICHAEL 3 fills | Director | Sell 10b5-1 | 12,500 | $71.11 | $888.9K | 1,364,675 −0.9% of holding | |
| SCHMERTZLER MICHAEL 2 fills | Director | Sell 10b5-1 | 12,500 | $73.32 | $916.6K | 1,381,259 −0.9% of holding | |
| Boulding Mark Elliott 2 fills | EXEC. VP AND CLO | Sell 10b5-1 | 2,813 | $72.57 | $204.1K | 106,241 −2.6% of holding | |
| Klein Matthew B. | CHIEF EXECUTIVE OFFICER | Sell | 10,292 | $68.57 | $705.7K | 383,868 −2.6% of holding | |
| Gravier Pierre | CHIEF FINANCIAL OFFICER | Sell | 3,494 | $80.35 | $280.7K | 83,986 −4% of holding | |
| Smith Mary L. 2 fills | Director | Sell 10b5-1 | 15,834 | $90.00 | $1.4M | 21,813 −42.1% of holding | |
| Almstead Neil Gregory | CHIEF TECHNICAL OPS OFFICER | Sell 10b5-1 | 2,464 | $90.25 | $222.4K | 60,299 −3.9% of holding | |
| Almstead Neil Gregory 3 fills | CHIEF TECHNICAL OPS OFFICER | Sell 10b5-1 | 24,613 | $88.89 | $2.2M | 80,956 −23.3% of holding | |
| Almstead Neil Gregory 5 fills | CHIEF TECHNICAL OPS OFFICER | Sell 10b5-1 | 22,161 | $86.00 | $1.9M | 70,389 −23.9% of holding | |
| Boulding Mark Elliott 8 fills | EXEC. VP AND CLO | Sell 10b5-1 | 5,079 | $85.08 | $432.1K | 107,698 −4.5% of holding | |
| Almstead Neil Gregory 2 fills | CHIEF TECHNICAL OPS OFFICER | Sell 10b5-1 | 8,130 | $85.26 | $693.2K | 60,137 −11.9% of holding | |
| Almstead Neil Gregory 5 fills | CHIEF TECHNICAL OPS OFFICER | Sell 10b5-1 | 20,960 | $85.97 | $1.8M | 71,474 −22.7% of holding | |
| Almstead Neil Gregory 2 fills | CHIEF TECHNICAL OPS OFFICER | Sell 10b5-1 | 5,323 | $85.03 | $452.6K | 60,137 −8.1% of holding | |
| Almstead Neil Gregory 2 fills | CHIEF TECHNICAL OPS OFFICER | Sell 10b5-1 | 23,749 | $80.90 | $1.9M | 71,756 −24.9% of holding | |
| Utter Christine Marie | SVP, CHIEF ACCOUNTING OFFICER | Sell 10b5-1 | 19,686 | $75.56 | $1.5M | 70,199 −21.9% of holding | |
| Boulding Mark Elliott 4 fills | EXEC. VP AND CLO | Sell 10b5-1 | 10,462 | $78.65 | $822.9K | 107,122 −8.9% of holding | |
| Pauwels Eric 2 fills | CHIEF BUSINESS OFFICER | Sell 10b5-1 | 21,277 | $75.00 | $1.6M | 73,411 −22.5% of holding | |
| Boulding Mark Elliott 2 fills | EXEC. VP AND CLO | Sell 10b5-1 | 2,812 | $72.18 | $203.0K | 105,668 −2.6% of holding | |
| Klein Matthew B. 4 fills | CHIEF EXECUTIVE OFFICER | Sell | 12,572 | $72.95 | $917.2K | 405,891 −3% of holding | |
| Boulding Mark Elliott 4 fills | EXEC. VP AND CLO | Sell 10b5-1 | 3,540 | $78.97 | $279.6K | 107,112 −3.2% of holding | |
| Klein Matthew B. | CHIEF EXECUTIVE OFFICER | Sell | 2,850 | $70.91 | $202.1K | 394,070 −0.7% of holding | |
| Boulding Mark Elliott 2 fills | EXEC. VP AND CLO | Sell 10b5-1 | 2,265 | $69.45 | $157.3K | 106,655 −2.1% of holding | |
| Golden Lee Scott | EVP & CHIEF MEDICAL OFFICER | Sell | 829 | $67.99 | $56.4K | 79,115 −1% of holding | |
| Almstead Neil Gregory 3 fills | CHIEF TECHNICAL OPS OFFICER | Sell 10b5-1 | 52,003 | $69.04 | $3.6M | 72,747 −41.7% of holding | |
| Klein Matthew B. | CHIEF EXECUTIVE OFFICER | Sell | 2,662 | $64.08 | $170.6K | 396,920 −0.7% of holding | |
| Okey Stephanie 2 fills | Director | Sell 10b5-1 | 15,167 | $70.00 | $1.1M | 8,000 −65.5% of holding | |
| Golden Lee Scott | EVP & CHIEF MEDICAL OFFICER | Sell 10b5-1 | 10,000 | $63.38 | $633.8K | 79,944 −11.1% of holding | |
| Okey Stephanie | Director | Sell 10b5-1 | 6,333 | $63.38 | $401.4K | 8,000 −44.2% of holding | |
| Almstead Neil Gregory | CHIEF TECHNICAL OPS OFFICER | Sell 10b5-1 | 3,989 | $63.38 | $252.8K | 2,737 −59.3% of holding | |
| Boulding Mark Elliott 4 fills | EXEC. VP AND CLO | Sell 10b5-1 | 3,019 | $69.48 | $209.8K | 107,643 −2.7% of holding | |
| Klein Matthew B. | CHIEF EXECUTIVE OFFICER | Sell | 7,371 | $69.36 | $511.3K | 387,082 −1.9% of holding | |
| Almstead Neil Gregory 2 fills | CHIEF TECHNICAL OPS OFFICER | Sell | 3,121 | $69.36 | $216.5K | 112,140 −2.7% of holding | |
| Boulding Mark Elliott | EXEC. VP AND CLO | Sell | 3,081 | $69.36 | $213.7K | 108,231 −2.8% of holding | |
| Pauwels Eric | CHIEF BUSINESS OFFICER | Sell | 3,019 | $69.36 | $209.4K | 77,122 −3.8% of holding | |
| Gravier Pierre | CHIEF FINANCIAL OFFICER | Sell | 2,992 | $69.36 | $207.5K | 87,318 −3.3% of holding | |
| Utter Christine Marie | SVP, CHIEF ACCOUNTING OFFICER | Sell | 2,494 | $69.36 | $173.0K | 70,199 −3.4% of holding | |
| Golden Lee Scott | EVP & CHIEF MEDICAL OFFICER | Sell | 2,484 | $69.36 | $172.3K | 89,944 −2.7% of holding | |
| Boulding Mark Elliott 2 fills | EXEC. VP AND CLO | Sell 10b5-1 | 2,813 | $69.29 | $194.9K | 111,314 −2.5% of holding | |
| Pauwels Eric | CHIEF BUSINESS OFFICER | Sell 10b5-1 | 1,024 | $78.70 | $80.6K | 80,141 −1.3% of holding | |
| Boulding Mark Elliott 3 fills | EXEC. VP AND CLO | Sell 10b5-1 | 2,314 | $77.93 | $180.3K | 112,105 −2% of holding | |
| Pauwels Eric | CHIEF BUSINESS OFFICER | Sell 10b5-1 | 1,722 | $77.41 | $133.3K | 81,165 −2.1% of holding | |
| Pauwels Eric 2 fills | CHIEF BUSINESS OFFICER | Sell 10b5-1 | 3,148 | $76.52 | $240.9K | 84,928 −3.6% of holding | |
| Boulding Mark Elliott 2 fills | EXEC. VP AND CLO | Sell 10b5-1 | 2,747 | $76.61 | $210.4K | 115,177 −2.3% of holding | |
| Klein Matthew B. | CHIEF EXECUTIVE OFFICER | Sell | 2,514 | $76.45 | $192.2K | 394,453 −0.6% of holding | |
| Pauwels Eric | CHIEF BUSINESS OFFICER | Sell | 1,454 | $76.45 | $111.2K | 82,887 −1.7% of holding | |
| Boulding Mark Elliott | EXEC. VP AND CLO | Sell | 1,286 | $76.45 | $98.3K | 113,626 −1.1% of holding | |
| Utter Christine Marie | SVP, CHIEF ACCOUNTING OFFICER | Sell | 1,034 | $76.45 | $79.0K | 72,693 −1.4% of holding | |
| Almstead Neil Gregory 2 fills | CHIEF TECHNICAL OPS OFFICER | Sell | 940 | $76.45 | $71.9K | 115,196 −0.8% of holding | |
| Golden Lee Scott | EVP & CHIEF MEDICAL OFFICER | Sell | 866 | $76.45 | $66.2K | 92,428 −0.9% of holding | |
| Boulding Mark Elliott 6 fills | EXEC. VP AND CLO | Sell 10b5-1 | 3,376 | $77.42 | $261.4K | 118,646 −2.8% of holding | |
| Klein Matthew B. | CHIEF EXECUTIVE OFFICER | Sell | 3,016 | $77.48 | $233.7K | 396,967 −0.8% of holding | |
| Boulding Mark Elliott | EXEC. VP AND CLO | Sell | 1,503 | $77.48 | $116.5K | 117,659 −1.3% of holding | |
| Pauwels Eric | CHIEF BUSINESS OFFICER | Sell | 1,352 | $77.48 | $104.8K | 87,489 −1.5% of holding | |
| Utter Christine Marie | SVP, CHIEF ACCOUNTING OFFICER | Sell | 1,235 | $77.45 | $95.7K | 73,727 −1.6% of holding | |
| Almstead Neil Gregory 2 fills | CHIEF TECHNICAL OPS OFFICER | Sell | 1,078 | $77.48 | $83.5K | 116,077 −0.9% of holding | |
| Golden Lee Scott | EVP & CHIEF MEDICAL OFFICER | Sell | 642 | $77.48 | $49.7K | 93,294 −0.7% of holding | |
| Klein Matthew B. | CHIEF EXECUTIVE OFFICER | Sell | 5,149 | $76.95 | $396.2K | 399,983 −1.3% of holding | |
| Gravier Pierre | CHIEF FINANCIAL OFFICER | Sell | 2,139 | $76.95 | $164.6K | 90,310 −2.3% of holding | |
| Pauwels Eric | CHIEF BUSINESS OFFICER | Sell | 1,789 | $76.95 | $137.7K | 88,841 −2% of holding | |
| Boulding Mark Elliott | EXEC. VP AND CLO | Sell | 1,739 | $76.95 | $133.8K | 119,162 −1.4% of holding | |
| Utter Christine Marie | SVP, CHIEF ACCOUNTING OFFICER | Sell | 1,381 | $76.95 | $106.3K | 74,962 −1.8% of holding | |
| Golden Lee Scott | EVP & CHIEF MEDICAL OFFICER | Sell | 1,340 | $76.95 | $103.1K | 93,936 −1.4% of holding | |
| Almstead Neil Gregory 2 fills | CHIEF TECHNICAL OPS OFFICER | Sell | 1,333 | $76.95 | $102.6K | 117,103 −1.1% of holding | |
| Boulding Mark Elliott 3 fills | EXEC. VP AND CLO | Sell 10b5-1 | 2,266 | $75.55 | $171.2K | 122,044 −1.8% of holding | |
| Reeve Emma | Director | Sell 10b5-1 | 734 | $76.00 | $55.8K | 10,666 −6.4% of holding | |
| STEELE GLENN JR MD PHD | Director | Sell 10b5-1 | 12,000 | $76.35 | $916.2K | 18,500 −39.3% of holding | |
| Klein Matthew B. | CHIEF EXECUTIVE OFFICER | Sell | 8,089 | $76.64 | $619.9K | 341,875 −2.3% of holding | |
| Pauwels Eric 10 fills | CHIEF BUSINESS OFFICER | Sell 10b5-1 | 20,508 | $77.26 | $1.6M | 88,678 −18.8% of holding | |
| Pauwels Eric 3 fills | CHIEF BUSINESS OFFICER | Sell 10b5-1 | 3,202 | $75.06 | $240.4K | 70,373 −4.4% of holding | |
| Pauwels Eric 5 fills | CHIEF BUSINESS OFFICER | Sell 10b5-1 | 40,290 | $75.43 | $3.0M | 72,912 −35.6% of holding | |
| Reeve Emma | Director | Sell 10b5-1 | 733 | $78.62 | $57.6K | 6,666 −9.9% of holding | |
| Klein Matthew B. | CHIEF EXECUTIVE OFFICER | Sell | 3,428 | $79.07 | $271.1K | 349,964 −1% of holding | |
| Almstead Neil Gregory 19 fills | CHIEF TECHNICAL OPS OFFICER | Sell 10b5-1 | 71,928 | $83.44 | $6.0M | 134,735 −34.8% of holding | |
| Jacobson Allan Steven 8 fills | Director | Sell 10b5-1 | 14,199 | $83.55 | $1.2M | 22,891 −38.3% of holding | |
| Almstead Neil Gregory 5 fills | CHIEF TECHNICAL OPS OFFICER | Sell 10b5-1 | 35,572 | $80.18 | $2.9M | 100,625 −26.1% of holding | |
| Jacobson Allan Steven 2 fills | Director | Sell 10b5-1 | 11,801 | $80.14 | $945.7K | 17,451 −40.3% of holding | |
| Reeve Emma | Director | Sell 10b5-1 | 10,000 | $79.50 | $795.0K | 6,666 −60% of holding | |
| Boulding Mark Elliott 3 fills | EXEC. VP AND CLO | Sell 10b5-1 | 2,812 | $75.99 | $213.7K | 104,870 −2.6% of holding | |
| Reeve Emma | Director | Sell 10b5-1 | 7,333 | $74.50 | $546.3K | 6,666 −52.4% of holding | |
| Reeve Emma 2 fills | Director | Sell 10b5-1 | 15,666 | $69.50 | $1.1M | 6,666 −70.2% of holding | |
| Boulding Mark Elliott 3 fills | EXEC. VP AND CLO | Sell 10b5-1 | 3,375 | $63.43 | $214.1K | 105,519 −3.1% of holding | |
| Boulding Mark Elliott | EXEC. VP AND CLO | Sell 10b5-1 | 2,266 | $65.07 | $147.4K | 103,901 −2.1% of holding | |
| Almstead Neil Gregory 6 fills | CHIEF TECHNICAL OPS OFFICER | Sell 10b5-1 | 55,000 | $66.05 | $3.6M | 128,764 −29.9% of holding | |
| Reeve Emma 9 fills | Director | Sell 10b5-1 | 25,562 | $65.96 | $1.7M | 17,304 −59.6% of holding | |
| Boulding Mark Elliott 10 fills | EXEC. VP AND CLO | Sell 10b5-1 | 22,655 | $65.82 | $1.5M | 118,925 −16% of holding | |
| Jacobson Allan Steven | Director | Sell 10b5-1 | 12,000 | $65.00 | $780.0K | 17,451 −40.7% of holding | |
| Boulding Mark Elliott 4 fills | EXEC. VP AND CLO | Sell 10b5-1 | 24,585 | $61.34 | $1.5M | 104,445 −19.1% of holding |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.